17 hours ago
4D Molecular Therapeutics reports positive 2-year Phase 2b data for 4D-150 in wet AMD, showing up to an 87% cut in treatment burden.
Key Efficacy Outcomes Through Two Years The Phase 2b study evaluated a single intravitreal dose of 4D-150 across two dosage levels, 3E10 vg/eye and 1E10 vg/eye, enrolling 45 total patients. The 3E10 vg/eye level was selected as the designated dose... Read more.
Owner: Perrotto Family through Community Media Group & Mississippi Valley Publishing
Owner: David Córdova through Información y Participación S.L.
Owner: Balkan Investigative Reporting Network (Non-profit, Gordana Igric Founder)
More from Benzinga
Owner: Jason Raznick
Owner: Jason Raznick
Owner: Jason Raznick
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
